Hayati Arvas
Dicle, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Serum Carcinoembryonic Antigen Levels Across Molecular Subtypes and Their Clinical and Prognostic Implications in Metastatic Non-Small Cell Lung Cancer.
Journal: Medicina (Kaunas, Lithuania)
Published: March 02, 2026
Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group.
Journal: Journal of clinical medicine
Published: March 01, 2026
Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients.
Journal: Scientific reports
Published: February 20, 2026
Real-world outcomes of trifluridine/tipiracil with or without bevacizumab in refractory metastatic colorectal cancer: a multicenter cohort study from Turkey.
Journal: Discover oncology
Published: February 09, 2026
Impact of renin-angiotensin system inhibitors on the clinical outcomes of nivolumab therapy in metastatic non-small cell lung cancer.
Journal: Expert review of anticancer therapy
Published: January 09, 2026
The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer.
Journal: Discover oncology
Published: November 22, 2025
Prognostic Significance of C-PLAN Index in Patients Treated with Immunotherapy for Non-Small-Cell Lung Cancer.
Journal: Journal of clinical medicine
Published: November 17, 2025
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: November 14, 2025
Last Updated: 09/26/2026